These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7768248)

  • 41. [Daily nutrient intake in hemodialysis].
    Bellizzi V; Di Iorio BR; Zamboli P; Terracciano V; Minutolo R; Iodice C; De Nicola L; Conte G
    G Ital Nefrol; 2003; 20(6):592-601. PubMed ID: 14732911
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Furosemide does not improve renal recovery after hemofiltration for acute renal failure in critically ill patients: a double blind randomized controlled trial.
    van der Voort PH; Boerma EC; Koopmans M; Zandberg M; de Ruiter J; Gerritsen RT; Egbers PH; Kingma WP; Kuiper MA
    Crit Care Med; 2009 Feb; 37(2):533-8. PubMed ID: 19114909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of furosemide on renal excretion of oxypurinol and purine bases.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T
    Metabolism; 2001 Feb; 50(2):241-5. PubMed ID: 11229436
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Addition of metolazone to overcome tolerance to furosemide in infants with bronchopulmonary dysplasia.
    Segar JL; Robillard JE; Johnson KJ; Bell EF; Chemtob S
    J Pediatr; 1992 Jun; 120(6):966-73. PubMed ID: 1593359
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Response of the kidney to furosemide. I. Effects of salt intake and renal compensation.
    Wilcox CS; Mitch WE; Kelly RA; Skorecki K; Meyer TW; Friedman PA; Souney PF
    J Lab Clin Med; 1983 Sep; 102(3):450-8. PubMed ID: 6886524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Plasma atrial natriuretic peptide level and urinary fractional sodium excretion (FENa) in patients with chronic renal failure].
    Czekalski S
    Pol Arch Med Wewn; 1990 Dec; 84(6):370-7. PubMed ID: 2151149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The comparison of the diuretic and natriuretic efficacy of continuous and bolus intravenous furosemide in patients with chronic kidney disease.
    Sanjay S; Annigeri RA; Seshadri R; Rao BS; Prakash KC; Mani MK
    Nephrology (Carlton); 2008 Jun; 13(3):247-50. PubMed ID: 18315706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic administration of furosemide augments renal weight and glomerular capillary pressure in normal rats.
    Lane PH; Tyler LD; Schmitz PG
    Am J Physiol; 1998 Aug; 275(2):F230-4. PubMed ID: 9691012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure.
    Dormans TP; Gerlag PG
    Eur Heart J; 1996 Dec; 17(12):1867-74. PubMed ID: 8960430
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A(1) receptor blockade induces natriuresis with a favorable renal hemodynamic profile in SHHF/Mcc-fa(cp) rats chronically treated with salt and furosemide.
    Jackson EK; Kost CK; Herzer WA; Smits GJ; Tofovic SP
    J Pharmacol Exp Ther; 2001 Dec; 299(3):978-87. PubMed ID: 11714886
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Furosemide kinetics and dynamics in patients with cirrhosis.
    Villeneuve JP; Verbeeck RK; Wilkinson GR; Branch RA
    Clin Pharmacol Ther; 1986 Jul; 40(1):14-20. PubMed ID: 3720175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients.
    Nakahama H; Orita Y; Yamazaki M; Itoh S; Okuda T; Yamaji A; Miwa Y; Yanase M; Fukuhara Y; Kamada T
    Nephron; 1988; 49(3):223-7. PubMed ID: 3398982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased nonrenal clearance and increased diuretic efficiency of furosemide in cystic fibrosis.
    Alván G; Beermann B; Hjelte L; Lind M; Lindholm A; Strandvik B
    Clin Pharmacol Ther; 1988 Oct; 44(4):436-41. PubMed ID: 3168395
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacological properties of the novel highly potent diuretic 7-chloro-2,3-dihydro-1-(2-methylbenzoyl)-4(1H)-quinolinone 4-oxime-O-sulfonic acid potassium salt.
    Shinkawa T; Yamasaki F; Kikuchi A; Nakakuki M; Nishijima K; Uemura A; Mizota M; Orita Y
    Arzneimittelforschung; 1992 Dec; 42(12):1466-72. PubMed ID: 1337698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Microinjection studies on the effect of furosemide on the rat nephron.
    Romano G; Federico E; Favret G; Bartoli E
    Kidney Blood Press Res; 1997; 20(4):240-6. PubMed ID: 9398029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the diuretic effect of furosemide mixed with human albumin or fresh frozen plasma for patients with hypoalbuminemia in the intensive care unit.
    Hsu CW; Lin SL; Sun SF; Chu KA; Chung HM; Chang HW
    J Nephrol; 2006; 19(5):621-7. PubMed ID: 17136691
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronopharmacological study of furosemide in human subjects.
    Tateishi T; Fujimura A; Miura T; Ebihara A
    Int J Clin Pharmacol Res; 1988; 8(6):401-7. PubMed ID: 3253217
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Similarities in functional state of the kidney in patients treated with CAPD and hemodialysis.
    van Olden RW; Krediet RT; Struijk DG; Arisz L
    Adv Perit Dial; 1996; 12():97-100. PubMed ID: 8865881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis.
    Assy N; Kayal M; Mejirisky Y; Gorenberg M; Hussein O; Schlesinger S
    BMC Gastroenterol; 2006 Nov; 6():39. PubMed ID: 17134488
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prostaglandin-independent protection by furosemide from oliguric ischemic renal failure in conscious rats.
    Kramer HJ; Schüürmann J; Wassermann C; Düsing R
    Kidney Int; 1980 Apr; 17(4):455-64. PubMed ID: 7392420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.